After Hours Summary: GME -13.4%, GWRE -3%, MDB -1.7% fall on earnings; RCKT +33.9% rockets on positive clinical dataAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: AVAV +1.8% (also to acquire Telerob)
Companies trading higher in after hours in reaction to news: RCKT +33.9% (announces "positive" data from Phase 1 trial of RP-A501), PRPH +12.3% (expands COVID-19 testing capacity), TTCF +7.5% (expands product range with plant-based meat alternatives), VIAV +1.7% (licensing agreement with Viko Optics for 3D sensing filters), ALBO +1.5% (submits NDA to FDA and a MAA to EMA seeking approval of odevixibat), UBER +1.4% (to invest a further $75 mln in Joby Aviation; Joby Aviation to acquire Uber Elevate), SDC +1.3% (granted patent for SmileShop retail concept), CRIS +1.1% (stock offering), CUBE +0.6% (increases dividend), PFE +0.6% (FDA accepts BLA for 20-valent pneumococcal conjugate vaccine candidate for priority review), MA +0.4% (increases dividend; approves new $6 bln repurchase program), ILMN +0.4% (announces risk-sharing agreement with Harvard Pilgrim), FMTX +0.3% (stock offering), RPAI +0.3% (increases dividend), MAA +0.1% (increases dividend), PNR +0.1% (increases dividend)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: GME -13.4% (comps -24.6%; also files mixed securities shelf offering), PHR -8.2% (also announces CFO transition), POWL -5.6%, GWRE -3%, MDB -1.7%, CHWY -0.9%
Companies trading lower in after hours in reaction to news: TCDA -9.6% (provides update on veverimer's development program), TALO -9.1% (stock offering), ICHR -8.3% (stock offering), FEYE -7.5% (co was breached by a foreign-government attack, according to WSJ), HOOK -6.7% (stock offering), BRP -3.9% (to acquire Burnham Benefits; also announces stock offering), AY -3.3% (stock offering), ASMB -2.6% (to wind down microbiome program), TJX -0.3% (increases dividend), SEIC -0.3% (increases dividend), CNS -0.1% (reports Nov AUM), UNVR -0.1% (expands distribution agreement with Solvay), JPM -0.1% (Jamie Dimon sees 2021 expenses topping $67 bln, according to Reuters)